LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

5.17 1.17

Buy Sell

Overview

Share price change

24h

Current

Min

5.03

Max

5.25

Key metrics
By Trading Economics
Income	4.1M -33M
Sales	6.1M 44M
EPS	-3.82
Profit margin	-75.213
Employees	279
EBITDA	9.2M -15M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+168.02% upside

Market Stats
By TradingEconomics
Market Cap	-5.6M 97M
Previous open	4
Previous close	5.17

News Sentiment

By Acuity

50%

168 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 lis 2025, 21:06 UTC

Major Market Movers

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8 lis 2025, 18:10 UTC

Earnings

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8 lis 2025, 13:10 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 lis 2025, 12:00 UTC

Earnings

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8 lis 2025, 10:30 UTC

Earnings

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8 lis 2025, 03:50 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 lis 2025, 03:41 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 lis 2025, 03:07 UTC

Acquisitions, Mergers, Takeovers

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 lis 2025, 22:36 UTC

Earnings

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 lis 2025, 22:22 UTC

Earnings

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q Rev $2.95B >CSU.T

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q Net $210M >CSU.T

7 lis 2025, 22:03 UTC

Earnings

Constellation Software 3Q EPS $9.89 >CSU.T

7 lis 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 lis 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 lis 2025, 20:59 UTC

Earnings

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 lis 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 lis 2025, 20:22 UTC

Earnings

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 lis 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 lis 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 lis 2025, 19:31 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 lis 2025, 19:17 UTC

Earnings

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 lis 2025, 19:09 UTC

Earnings

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 lis 2025, 19:08 UTC

Earnings

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 lis 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 lis 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 lis 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

168.02% upside

12 Months Forecast

Average 13.83 USD 168.02%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

168 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

Other stocks from the sector

LLY

Eli Lilly and Co.

922.39

↓-1.51%

JNJ

Johnson and Johnson

186.29

↓-0.03%

UNH

UnitedHealth Group Inc

324.11

↑ +0.82%

NVS

Novartis AG

126.28

↓-0.09%

ABT

Abbott Laboratories

126.19

↑ +1.02%

Karyopharm Therapeutics Inc

Overview

Share price change

Key metrics

Recommendations

Market Stats

News Sentiment

Technical Score

Karyopharm Therapeutics Inc Chart

Related News

Peer Comparison

Karyopharm Therapeutics Inc Forecast

Price Target

Rating Consensus

Technical Score

Sentiment

Financials

Other stocks from the sector